Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 7847 | 24.45 |
09:34 ET | 800 | 24.3 |
09:36 ET | 600 | 24.245 |
09:38 ET | 450 | 24.215 |
09:39 ET | 500 | 24.26 |
09:41 ET | 2242 | 24.36 |
09:43 ET | 2738 | 24.36 |
09:45 ET | 1145 | 24.38 |
09:48 ET | 300 | 24.365 |
09:50 ET | 2324 | 24.42 |
09:52 ET | 949 | 24.35 |
09:54 ET | 300 | 24.35 |
09:56 ET | 1627 | 24.385 |
09:57 ET | 500 | 24.39 |
09:59 ET | 3943 | 24.36 |
10:01 ET | 2112 | 24.285 |
10:03 ET | 937 | 24.31 |
10:06 ET | 2045 | 24.3 |
10:08 ET | 2433 | 24.3 |
10:10 ET | 2022 | 24.32 |
10:12 ET | 1915 | 24.34 |
10:14 ET | 1880 | 24.37 |
10:15 ET | 6348 | 24.35 |
10:17 ET | 600 | 24.35 |
10:19 ET | 1477 | 24.36 |
10:21 ET | 6395 | 24.35 |
10:24 ET | 3413 | 24.35 |
10:26 ET | 1476 | 24.36 |
10:28 ET | 2712 | 24.29 |
10:30 ET | 2389 | 24.33 |
10:32 ET | 2732 | 24.335 |
10:33 ET | 704 | 24.34 |
10:35 ET | 3741 | 24.35 |
10:37 ET | 6158 | 24.34 |
10:39 ET | 770 | 24.335 |
10:42 ET | 2432 | 24.37 |
10:44 ET | 1700 | 24.38 |
10:46 ET | 1073 | 24.38 |
10:48 ET | 7715 | 24.365 |
10:50 ET | 2050 | 24.35 |
10:51 ET | 1439 | 24.345 |
10:53 ET | 4576 | 24.29 |
10:55 ET | 600 | 24.3 |
10:57 ET | 3482 | 24.3 |
11:00 ET | 4777 | 24.295 |
11:02 ET | 930 | 24.315 |
11:04 ET | 100 | 24.32 |
11:06 ET | 1100 | 24.33 |
11:08 ET | 2404 | 24.33 |
11:09 ET | 2660 | 24.33 |
11:11 ET | 6741 | 24.315 |
11:13 ET | 250 | 24.36 |
11:15 ET | 2114 | 24.34 |
11:18 ET | 3489 | 24.31 |
11:20 ET | 1389 | 24.315 |
11:22 ET | 4564 | 24.28 |
11:24 ET | 1500 | 24.29 |
11:26 ET | 3500 | 24.285 |
11:27 ET | 600 | 24.27 |
11:29 ET | 3522 | 24.24 |
11:31 ET | 3810 | 24.265 |
11:33 ET | 1975 | 24.25 |
11:36 ET | 2378 | 24.26 |
11:38 ET | 3890 | 24.265 |
11:40 ET | 200 | 24.29 |
11:42 ET | 2543 | 24.29 |
11:44 ET | 1237 | 24.28 |
11:45 ET | 2883 | 24.28 |
11:47 ET | 1515 | 24.265 |
11:49 ET | 2000 | 24.26 |
11:51 ET | 671 | 24.265 |
11:54 ET | 3313 | 24.27 |
11:56 ET | 2450 | 24.27 |
11:58 ET | 1100 | 24.27 |
12:00 ET | 1200 | 24.265 |
12:02 ET | 1034 | 24.27 |
12:03 ET | 300 | 24.27 |
12:05 ET | 10831 | 24.24 |
12:07 ET | 2777 | 24.235 |
12:09 ET | 1859 | 24.23 |
12:12 ET | 4078 | 24.17 |
12:14 ET | 1803 | 24.16 |
12:16 ET | 850 | 24.19 |
12:18 ET | 4459 | 24.19 |
12:20 ET | 2929 | 24.21 |
12:21 ET | 5117 | 24.16 |
12:23 ET | 300 | 24.15 |
12:25 ET | 4216 | 24.16 |
12:27 ET | 2154 | 24.15 |
12:30 ET | 4200 | 24.14 |
12:32 ET | 907 | 24.145 |
12:34 ET | 1137 | 24.16 |
12:36 ET | 5366 | 24.17 |
12:38 ET | 2193 | 24.17 |
12:39 ET | 1000 | 24.17 |
12:41 ET | 100 | 24.17 |
12:43 ET | 4804 | 24.19 |
12:45 ET | 2888 | 24.15 |
12:48 ET | 2402 | 24.1323 |
12:50 ET | 1873 | 24.17 |
12:52 ET | 450 | 24.17 |
12:54 ET | 6957 | 24.19 |
12:56 ET | 300 | 24.19 |
12:57 ET | 2950 | 24.21 |
12:59 ET | 2101 | 24.19 |
01:01 ET | 2784 | 24.175 |
01:03 ET | 1403 | 24.18 |
01:06 ET | 1102 | 24.17 |
01:08 ET | 637 | 24.17 |
01:10 ET | 2018 | 24.16 |
01:12 ET | 500 | 24.16 |
01:14 ET | 1703 | 24.16 |
01:15 ET | 2160 | 24.14 |
01:17 ET | 1081 | 24.125 |
01:19 ET | 625 | 24.13 |
01:21 ET | 5105 | 24.12 |
01:24 ET | 1777 | 24.15 |
01:26 ET | 2675 | 24.14 |
01:28 ET | 3573 | 24.14 |
01:30 ET | 200 | 24.15 |
01:32 ET | 2630 | 24.16 |
01:33 ET | 1000 | 24.19 |
01:37 ET | 2739 | 24.18 |
01:39 ET | 2099 | 24.17 |
01:42 ET | 100 | 24.18 |
01:44 ET | 6828 | 24.165 |
01:46 ET | 932 | 24.17 |
01:48 ET | 1700 | 24.15 |
01:50 ET | 2268 | 24.14 |
01:51 ET | 200 | 24.13 |
01:53 ET | 3458 | 24.12 |
01:55 ET | 800 | 24.14 |
01:57 ET | 1649 | 24.145 |
02:00 ET | 1083 | 24.175 |
02:02 ET | 7243 | 24.16 |
02:04 ET | 1863 | 24.14 |
02:06 ET | 905 | 24.15 |
02:08 ET | 14774 | 24.14 |
02:09 ET | 1000 | 24.16 |
02:11 ET | 1526 | 24.16 |
02:13 ET | 3941 | 24.165 |
02:15 ET | 4743 | 24.175 |
02:18 ET | 400 | 24.17 |
02:20 ET | 641 | 24.175 |
02:22 ET | 800 | 24.17 |
02:24 ET | 800 | 24.17 |
02:26 ET | 2114 | 24.16 |
02:27 ET | 500 | 24.165 |
02:29 ET | 1898 | 24.175 |
02:31 ET | 1257 | 24.16 |
02:33 ET | 2808 | 24.155 |
02:36 ET | 1000 | 24.155 |
02:38 ET | 600 | 24.15 |
02:40 ET | 3684 | 24.155 |
02:42 ET | 700 | 24.145 |
02:44 ET | 1377 | 24.145 |
02:45 ET | 954 | 24.145 |
02:47 ET | 1865 | 24.125 |
02:49 ET | 2016 | 24.14 |
02:51 ET | 700 | 24.145 |
02:54 ET | 2359 | 24.15 |
02:56 ET | 1776 | 24.15 |
02:58 ET | 2902 | 24.135 |
03:00 ET | 1996 | 24.14 |
03:02 ET | 4055 | 24.13 |
03:03 ET | 1200 | 24.15 |
03:05 ET | 1303 | 24.15 |
03:07 ET | 2011 | 24.14 |
03:09 ET | 500 | 24.145 |
03:12 ET | 1265 | 24.145 |
03:14 ET | 2482 | 24.145 |
03:16 ET | 2350 | 24.14 |
03:18 ET | 1175 | 24.135 |
03:20 ET | 814 | 24.135 |
03:21 ET | 1136 | 24.115 |
03:23 ET | 5013 | 24.115 |
03:25 ET | 1100 | 24.101 |
03:27 ET | 1525 | 24.11 |
03:30 ET | 3551 | 24.13 |
03:32 ET | 2500 | 24.135 |
03:34 ET | 1029 | 24.135 |
03:36 ET | 2883 | 24.14 |
03:38 ET | 1222 | 24.14 |
03:39 ET | 1904 | 24.135 |
03:41 ET | 12296 | 24.14 |
03:43 ET | 5758 | 24.135 |
03:45 ET | 2875 | 24.13 |
03:48 ET | 4710 | 24.12 |
03:50 ET | 3647 | 24.125 |
03:52 ET | 7554 | 24.12 |
03:54 ET | 10136 | 24.11 |
03:56 ET | 24558 | 24.05 |
03:57 ET | 19496 | 24.07 |
03:59 ET | 259983 | 24.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.1B | 6.9x | --- |
Exelixis Inc | 6.2B | 33.0x | -21.77% |
PTC Therapeutics Inc | 2.5B | -4.2x | --- |
P3 Health Partners Inc | 212.3M | -1.0x | --- |
Halozyme Therapeutics Inc | 5.5B | 17.8x | --- |
Novavax Inc | 1.2B | -1.6x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.9x |
Price/Sales (TTM) | 2.4 |
Price/Cash Flow (TTM) | 6.1x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.